<?xml version='1.0' encoding='utf-8'?>
<document id="26588196"><sentence text="Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects."><entity charOffset="0-11" id="DDI-PubMed.26588196.s1.e0" text="Paracetamol" /><entity charOffset="47-58" id="DDI-PubMed.26588196.s1.e1" text="lamotrigine" /><pair ddi="false" e1="DDI-PubMed.26588196.s1.e0" e2="DDI-PubMed.26588196.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s1.e0" e2="DDI-PubMed.26588196.s1.e1" /></sentence><sentence text="Patients receiving lamotrigine therapy frequently use paracetamol concomitantly"><entity charOffset="19-30" id="DDI-PubMed.26588196.s2.e0" text="lamotrigine" /><entity charOffset="54-65" id="DDI-PubMed.26588196.s2.e1" text="paracetamol" /><pair ddi="false" e1="DDI-PubMed.26588196.s2.e0" e2="DDI-PubMed.26588196.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s2.e0" e2="DDI-PubMed.26588196.s2.e1" /></sentence><sentence text=" While one study suggests a possible, clinically relevant drug-drug interaction, practical recommendations of the concomitant use are inconsistent" /><sentence text=" We performed a systematic pharmacokinetic study in healthy volunteers to quantify the effect of 4 day treatment with paracetamol on the metabolism of steady-state lamotrigine"><entity charOffset="118-129" id="DDI-PubMed.26588196.s4.e0" text="paracetamol" /><entity charOffset="164-175" id="DDI-PubMed.26588196.s4.e1" text="lamotrigine" /><pair ddi="false" e1="DDI-PubMed.26588196.s4.e0" e2="DDI-PubMed.26588196.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s4.e0" e2="DDI-PubMed.26588196.s4.e1" /></sentence><sentence text="" /><sentence text="Twelve healthy, male volunteers participated in an open label, sequential interaction study" /><sentence text=" Lamotrigine was titrated to steady-state (100 mg daily) over 36 days, and blood and urine sampling was performed in a non-randomized order with and without paracetamol (1 g four times daily)"><entity charOffset="1-12" id="DDI-PubMed.26588196.s7.e0" text="Lamotrigine" /><entity charOffset="157-168" id="DDI-PubMed.26588196.s7.e1" text="paracetamol" /><pair ddi="false" e1="DDI-PubMed.26588196.s7.e0" e2="DDI-PubMed.26588196.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s7.e0" e2="DDI-PubMed.26588196.s7.e1" /></sentence><sentence text=" The primary endpoint was change in steady-state area under the plasma concentration-time curve of lamotrigine"><entity charOffset="99-110" id="DDI-PubMed.26588196.s8.e0" text="lamotrigine" /></sentence><sentence text=" Secondary endpoints were changes in total apparent oral clearance, renal clearance, trough concentration of lamotrigine and formation clearance of lamotrigine glucuronide conjugates"><entity charOffset="109-120" id="DDI-PubMed.26588196.s9.e0" text="lamotrigine" /><entity charOffset="148-171" id="DDI-PubMed.26588196.s9.e1" text="lamotrigine glucuronide" /><pair ddi="false" e1="DDI-PubMed.26588196.s9.e0" e2="DDI-PubMed.26588196.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s9.e0" e2="DDI-PubMed.26588196.s9.e1" /></sentence><sentence text="" /><sentence text="Co-administration of lamotrigine and paracetamol decreased the steady-state area under the plasma concentration-time curve of lamotrigine by 20% (95% CI 10%, 25%; P &lt; 0"><entity charOffset="21-32" id="DDI-PubMed.26588196.s11.e0" text="lamotrigine" /><entity charOffset="37-48" id="DDI-PubMed.26588196.s11.e1" text="paracetamol" /><entity charOffset="126-137" id="DDI-PubMed.26588196.s11.e2" text="lamotrigine" /><entity charOffset="150-152" id="DDI-PubMed.26588196.s11.e3" text="CI" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e0" e2="DDI-PubMed.26588196.s11.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e0" e2="DDI-PubMed.26588196.s11.e1" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e0" e2="DDI-PubMed.26588196.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e0" e2="DDI-PubMed.26588196.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e1" e2="DDI-PubMed.26588196.s11.e1" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e1" e2="DDI-PubMed.26588196.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e1" e2="DDI-PubMed.26588196.s11.e3" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e2" e2="DDI-PubMed.26588196.s11.e2" /><pair ddi="false" e1="DDI-PubMed.26588196.s11.e2" e2="DDI-PubMed.26588196.s11.e3" /></sentence><sentence text="001) from 166 to 127 μmol l(-1) " /><sentence text=" Concomitant administration of paracetamol increased the formation clearance of lamotrigine glucuronide conjugates by 45% (95% CI 18%, 79%, P = 0"><entity charOffset="31-42" id="DDI-PubMed.26588196.s13.e0" text="paracetamol" /><entity charOffset="80-103" id="DDI-PubMed.26588196.s13.e1" text="lamotrigine glucuronide" /><entity charOffset="127-149" id="DDI-PubMed.26588196.s13.e2" text="CI" /><pair ddi="false" e1="DDI-PubMed.26588196.s13.e0" e2="DDI-PubMed.26588196.s13.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s13.e0" e2="DDI-PubMed.26588196.s13.e1" /><pair ddi="false" e1="DDI-PubMed.26588196.s13.e0" e2="DDI-PubMed.26588196.s13.e2" /><pair ddi="false" e1="DDI-PubMed.26588196.s13.e1" e2="DDI-PubMed.26588196.s13.e1" /><pair ddi="false" e1="DDI-PubMed.26588196.s13.e1" e2="DDI-PubMed.26588196.s13.e2" /></sentence><sentence text="005) from 1" /><sentence text="7 to 2" /><sentence text="8 l h(-1) , while the trough value of lamotrigine was reduced by 25% (95% CI 12%, 36%, P = 0"><entity charOffset="38-49" id="DDI-PubMed.26588196.s16.e0" text="lamotrigine" /><entity charOffset="74-84" id="DDI-PubMed.26588196.s16.e1" text="CI" /><pair ddi="false" e1="DDI-PubMed.26588196.s16.e0" e2="DDI-PubMed.26588196.s16.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s16.e0" e2="DDI-PubMed.26588196.s16.e1" /></sentence><sentence text="003) from 5" /><sentence text="3 to 3" /><sentence text="9 μmol l(-1) " /><sentence text="" /><sentence text="Paracetamol statistically significantly induced steady-state lamotrigine glucuronidation, resulting in a 20% decrease in total systemic exposure and a 25% decrease in trough value of lamotrigine"><entity charOffset="0-11" id="DDI-PubMed.26588196.s21.e0" text="Paracetamol" /><entity charOffset="61-72" id="DDI-PubMed.26588196.s21.e1" text="lamotrigine" /><entity charOffset="183-194" id="DDI-PubMed.26588196.s21.e2" text="lamotrigine" /><pair ddi="false" e1="DDI-PubMed.26588196.s21.e0" e2="DDI-PubMed.26588196.s21.e0" /><pair ddi="false" e1="DDI-PubMed.26588196.s21.e0" e2="DDI-PubMed.26588196.s21.e1" /><pair ddi="false" e1="DDI-PubMed.26588196.s21.e0" e2="DDI-PubMed.26588196.s21.e2" /><pair ddi="false" e1="DDI-PubMed.26588196.s21.e1" e2="DDI-PubMed.26588196.s21.e1" /><pair ddi="false" e1="DDI-PubMed.26588196.s21.e1" e2="DDI-PubMed.26588196.s21.e2" /></sentence><sentence text=" This interaction may be of clinical relevance in some patients" /><sentence text="" /></document>